Developer docs
API playgroundTry for free, no card

Search company profiles

Pelagen

Full company profile

uuid000bejp

Namestring
Pelagen
Legal namestring
Pelagen
Websiteurl
pelagen.bio
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Pelagen is a Leiden, Netherlands-based biotech startup founded in 2020 that develops biofabricated natural materials using proprietary skin tissue engineering technology. The company's core technology engineers skin tissue from cells without animals, leveraging decades of biomedical research from Leiden University Medical Center — Europe's pioneer in skin engineering — under the leadership of CSO Prof. Abdoel el Ghalbzouri. The closely-held IP suite spans cell selection to tissue cultivation methods, enabling the production of plastic-free leather described as one-to-one comparable with traditional animal-derived leather, with planned extensions into fur and wool alternatives.

The company offers a single core product — Engineered Leather — applicable across three primary verticals: fashion (accessories, apparel, footwear), automotive (vehicle interiors), and interior design and furniture. Pelagen operates a B2B enterprise sales model targeting major brands in these verticals through direct sales, with prospective customers engaging via a 'request a deck' inquiry mechanism on the company website. Pricing is not publicly disclosed, suggesting quote-based, custom enterprise contracts. The company also references a one-time license revenue stream in source data.

Pelagen is a private, venture-backed company in early commercialization stage with 1-10 employees. It has received two funding rounds: an investment from Dutch incubator YES!Delft in October 2021 and from Dutch fund UNIIQ in October 2023, with specific amounts undisclosed. The company displays EU co-funding branding, suggesting participation in European innovation programs. No customers, revenue figures, patents, awards, or regulatory certifications are disclosed in available sources, indicating Pelagen remains in pre-commercial or early pilot-stage commercialization.

Short descriptiontext

Pelagen is a Leiden-based biotech startup that produces biofabricated leather from cultured cells without animals, leveraging proprietary tissue engineering IP from Leiden University Medical Center to serve fashion, automotive, and interior design brands.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLeiden, Netherlands
HQ citystring
Leiden
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biofabricated leather, cell-cultured materials, tissue engineering, animal-free leather, sustainable materials
Industry3 codes
PRIMARYIMAOAHAH
Vegan/Alternative Material Goods Manufacturing (PU/Plant-based/Mycelium)
SECONDARYHLAAAGAG
Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYCRAAAMAG
Leather, Suede & Alternatives (PU/Bio-based)
Consumer Products & Retail/Apparel, Footwear & Accessories/Textiles, Fabrics & Trims (Inputs & Sourcing)
NAICS code3 codes
  • Leather and Allied Product Manufacturing316
  • Leather and Hide Tanning and Finishing31611
  • Other Leather and Allied Product Manufacturing31699
SIC code2 codes
  • Leather & Leather Products3100
  • Biological Products, (No Disgnostic Substances)2836
Product category
Biofabricated Leather Materials
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Biofabricated Materials Sales
TypeOne Time License
Description

Pelagen generates revenue through the sale of biofabricated leather and natural materials produced via their cell-based technology. The materials are positioned as animal-free alternatives for fashion, automotive, interiors, and other applications. The company appears to be in development/commercialization stage targeting enterprise buyers.

pelagen.bio
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Pelagen produces biofabricated leather by engineering skin tissue from cells without animals. The proprietary technology, developed at Leiden University Medical Center, cultivates living tissue that is transformed into leather material with quality characteristics comparable to traditional animal leather, sold as an animal-free alternative for fashion, automotive, interiors, and other applications.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Pelagen offers a single core product: Engineered Leather, a biofabricated natural material produced without animals. The company's technology engineers skin tissue from cells using proprietary methods developed at Leiden University Medical Center. The living tissue is cultivated and then transformed into leather material that matches the biological complexity and quality of traditional animal leather, serving as an animal-free alternative for fashion, automotive, interiors, and other applications.

Product and service1 record
1Engineered Leather
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leiden University Medical Center is Europe's pioneer in skin engineering. Pelagen leverages decades of medical research leadership from LUMC, which serves as the foundation for their tissue engineering technology and provides scientific expertise through their CSO Prof. Abdoel el Ghalbzouri.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

MycoWorks produces Fine Mycelium, a mycelium-based leather alternative, and has secured a high-profile partnership with Hermès. While it uses a different biology (fungal vs. mammalian cells), it competes head-to-head with Pelagen for fashion and luxury leather buyers seeking premium sustainable materials.

TypeBroad incumbent
Description

Spiber (Japan) produces Brewed Protein, a fermentation-derived protein fiber used as a leather alternative. Although fiber-based rather than cell-cultivated tissue, Spiber is a well-funded category leader pursuing apparel and automotive customers in the same premium materials market as Pelagen.

TypeEmerging player
Description

Desserto makes cactus-based vegan leather for fashion, automotive interiors, and upholstery. It overlaps with Pelagen on automotive and interior verticals but uses plant biomass rather than cell-cultivated tissue, positioning at a lower price point.

TypeEmerging player
Description

Ecovative uses mycelium technology (Forager platform) to produce leather-like and packaging materials. It is a more established adjacent player in bio-fabricated materials with broader product lines, sharing the alternative leather end market with Pelagen.

TypeDirect peer
Description

VitroLabs is a California-based startup growing cell-cultivated leather from animal cells without slaughter. It pursues the same core thesis as Pelagen — animal-free leather with biological parity to conventional leather — and targets luxury fashion and automotive OEMs as initial customers.

TypeEmerging player
Description

TômTex develops chitosan-based (shellfish-waste-derived) leather alternatives aimed at fashion and accessories. It is a smaller, design-led entrant competing for sustainable-material brand interest similar to Pelagen's fashion customer base.

TypeEmerging player
Description

Ananas Anam produces Piñatex, a pineapple-leaf-fiber leather alternative. It serves fashion and footwear brands with a plant-based, non-cultivated leather, competing for some of the same sustainable-material buyers as Pelagen but with a very different feedstock and price point.

TypeDirect peer
Description

Modern Meadow is a US-based biotech developing cell-cultivated and bio-fabricated leather and other protein-based materials. It is the closest direct peer to Pelagen, using cell-based and fermentation-derived approaches to produce next-generation leather for fashion and automotive applications.

TypeBroad incumbent
Description

Bolt Threads, now operating its materials business as Forager, develops mycelium- and fermentation-based leather and protein materials. It competes for the same fashion and footwear customers and has broader scale and brand partnerships than Pelagen today.

TypeOthers
Description

LUMC is Pelagen's core scientific partner and the source of its tissue-engineering IP and CSO expertise. It is not a commercial competitor but functions as an enabling research institution whose continued collaboration underpins Pelagen's technology pipeline.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pelagen

Biofabricated Leather Materialspelagen.bio

Pelagen is a Leiden-based biotech startup that produces biofabricated leather from cultured cells without animals, leveraging proprietary tissue engineering IP from Leiden University Medical Center to serve fashion, automotive, and interior design brands.

What Pelagen does

Pelagen is a Leiden, Netherlands-based biotech startup founded in 2020 that develops biofabricated natural materials using proprietary skin tissue engineering technology. The company's core technology engineers skin tissue from cells without animals, leveraging decades of biomedical research from Leiden University Medical Center — Europe's pioneer in skin engineering — under the leadership of CSO Prof. Abdoel el Ghalbzouri. The closely-held IP suite spans cell selection to tissue cultivation methods, enabling the production of plastic-free leather described as one-to-one comparable with traditional animal-derived leather, with planned extensions into fur and wool alternatives.

The company offers a single core product — Engineered Leather — applicable across three primary verticals: fashion (accessories, apparel, footwear), automotive (vehicle interiors), and interior design and furniture. Pelagen operates a B2B enterprise sales model targeting major brands in these verticals through direct sales, with prospective customers engaging via a 'request a deck' inquiry mechanism on the company website. Pricing is not publicly disclosed, suggesting quote-based, custom enterprise contracts. The company also references a one-time license revenue stream in source data.

Pelagen is a private, venture-backed company in early commercialization stage with 1-10 employees. It has received two funding rounds: an investment from Dutch incubator YES!Delft in October 2021 and from Dutch fund UNIIQ in October 2023, with specific amounts undisclosed. The company displays EU co-funding branding, suggesting participation in European innovation programs. No customers, revenue figures, patents, awards, or regulatory certifications are disclosed in available sources, indicating Pelagen remains in pre-commercial or early pilot-stage commercialization.

Pelagen firmographics

Firmographics
Name
Pelagen
Legal name
Pelagen
Website
https://pelagen.bio
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Pelagen is a Leiden-based biotech startup that produces biofabricated leather from cultured cells without animals, leveraging proprietary tissue engineering IP from Leiden University Medical Center to serve fashion, automotive, and interior design brands.
Ownership category
akta.pro rank

Pelagen industry classification

Industry
Product category
Biofabricated Leather Materials
NAICS
Leather and Allied Product Manufacturing (316), Leather and Hide Tanning and Finishing (31611), Other Leather and Allied Product Manufacturing (31699)
SIC
Leather & Leather Products (3100), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYIMAOAHAH
Vegan/Alternative Material Goods Manufacturing (PU/Plant-based/Mycelium)
SECONDARYHLAAAGAG
Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYCRAAAMAG
Leather, Suede & Alternatives (PU/Bio-based)
Consumer Products & Retail/Apparel, Footwear & Accessories/Textiles, Fabrics & Trims (Inputs & Sourcing)

Keywords

  • Biofabricated leather
  • Cell-cultured materials
  • Tissue engineering
  • Animal-free leather
  • Sustainable materials

Where Pelagen is headquartered

Location

Headquarters

HQ city
Leiden
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

Pelagen business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain

Revenue model

  1. Biofabricated Materials Sales: Pelagen generates revenue through the sale of biofabricated leather and natural materials produced via their cell-based technology. The materials are positioned as animal-free alternatives for fashion, automotive, interiors, and other applications. The company appears to be in development/commercialization stage targeting enterprise buyers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Pelagen product offering

Product offering

Core offering

Pelagen produces biofabricated leather by engineering skin tissue from cells without animals. The proprietary technology, developed at Leiden University Medical Center, cultivates living tissue that is transformed into leather material with quality characteristics comparable to traditional animal leather, sold as an animal-free alternative for fashion, automotive, interiors, and other applications.

Product overview

Pelagen offers a single core product: Engineered Leather, a biofabricated natural material produced without animals. The company's technology engineers skin tissue from cells using proprietary methods developed at Leiden University Medical Center. The living tissue is cultivated and then transformed into leather material that matches the biological complexity and quality of traditional animal leather, serving as an animal-free alternative for fashion, automotive, interiors, and other applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Engineered Leather

Companies that use Pelagen

Customer profile

Segments3 records

Ideal customer profiles3 records

Pelagen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Pelagen partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Leiden University Medical CentercoreStrategic or Co-development PartnerLeiden University Medical Center is Europe's pioneer in skin engineering. Pelagen leverages decades of medical research leadership from LUMC, which serves as the foundation for their tissue engineering technology and provides scientific expertise through their CSO Prof. Abdoel el Ghalbzouri.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Pelagen competitors and assessment

Company assessment

Broad incumbents

  • MycoWorks: MycoWorks produces Fine Mycelium, a mycelium-based leather alternative, and has secured a high-profile partnership with Hermès. While it uses a different biology (fungal vs. mammalian cells), it competes head-to-head with Pelagen for fashion and luxury leather buyers seeking premium sustainable materials.
  • Spiber: Spiber (Japan) produces Brewed Protein, a fermentation-derived protein fiber used as a leather alternative. Although fiber-based rather than cell-cultivated tissue, Spiber is a well-funded category leader pursuing apparel and automotive customers in the same premium materials market as Pelagen.
  • Bolt Threads (Forager): Bolt Threads, now operating its materials business as Forager, develops mycelium- and fermentation-based leather and protein materials. It competes for the same fashion and footwear customers and has broader scale and brand partnerships than Pelagen today.

Emerging players

  • Desserto: Desserto makes cactus-based vegan leather for fashion, automotive interiors, and upholstery. It overlaps with Pelagen on automotive and interior verticals but uses plant biomass rather than cell-cultivated tissue, positioning at a lower price point.
  • Ecovative Design: Ecovative uses mycelium technology (Forager platform) to produce leather-like and packaging materials. It is a more established adjacent player in bio-fabricated materials with broader product lines, sharing the alternative leather end market with Pelagen.
  • TômTex: TômTex develops chitosan-based (shellfish-waste-derived) leather alternatives aimed at fashion and accessories. It is a smaller, design-led entrant competing for sustainable-material brand interest similar to Pelagen's fashion customer base.
  • Ananas Anam (Piñatex): Ananas Anam produces Piñatex, a pineapple-leaf-fiber leather alternative. It serves fashion and footwear brands with a plant-based, non-cultivated leather, competing for some of the same sustainable-material buyers as Pelagen but with a very different feedstock and price point.

Direct peers

  • VitroLabs: VitroLabs is a California-based startup growing cell-cultivated leather from animal cells without slaughter. It pursues the same core thesis as Pelagen — animal-free leather with biological parity to conventional leather — and targets luxury fashion and automotive OEMs as initial customers.
  • Modern Meadow: Modern Meadow is a US-based biotech developing cell-cultivated and bio-fabricated leather and other protein-based materials. It is the closest direct peer to Pelagen, using cell-based and fermentation-derived approaches to produce next-generation leather for fashion and automotive applications.

Others

  • Leiden University Medical Center (LUMC): LUMC is Pelagen's core scientific partner and the source of its tissue-engineering IP and CSO expertise. It is not a commercial competitor but functions as an enabling research institution whose continued collaboration underpins Pelagen's technology pipeline.

Market position

Strengths4 records

Weaknesses1 record

Competitive moat3 records

Key risks1 record

Key highlights6 records

Customer concentration

Pelagen social profiles

Digital presence

Pelagen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pelagen leadership team

Management profile

Number of profiles

Profiles1 record

Pelagen funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pelagen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pelagen

What does Pelagen do?

Pelagen produces biofabricated leather by engineering skin tissue from cells without animals. The proprietary technology, developed at Leiden University Medical Center, cultivates living tissue that is transformed into leather material with quality characteristics comparable to traditional animal leather, sold as an animal-free alternative for fashion, automotive, interiors, and other applications.

Is Pelagen a public or private company?

Pelagen is a private company. It is classified as venture growth investor backed and is currently operating.

When was Pelagen founded?

Pelagen was founded in 2020. It employs 1 to 10 people.

Where is Pelagen based?

Pelagen is headquartered in Leiden, Netherlands, in the Europe region.

How does Pelagen make money?

One revenue line is on record: biofabricated Materials Sales.

Who are Pelagen's main competitors?

Broad incumbents on record are MycoWorks, Spiber and Bolt Threads (Forager). Emerging players are Desserto, Ecovative Design, TômTex and Ananas Anam (Piñatex). Direct peers are VitroLabs and Modern Meadow. Leiden University Medical Center (LUMC) is listed as an others.

Does Pelagen have an API?

No public API is recorded for Pelagen.

What industry is Pelagen in?

Pelagen's product category is Biofabricated Leather Materials. Its primary akta.pro industry code is IMAOAHAH, Vegan/Alternative Material Goods Manufacturing (PU/Plant-based/Mycelium), with a secondary code of HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 316 and its SIC code is 3100.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EthosCultivated Meat May Be At a Standstill, But What About Lab-Grown Leather?While the cultivated meat industry faces significant operational and regulatory hurdles, companies like Qorium and Modern Meadow are advancing cell-cultured leather production with new investments and strategic partnerships. Meatable recently collaborated with Pelagen to pivot its technology toward animal-free leather, signaling a shift in focus within the biotech materials sector.iGrow NewsMeatable & Pelagen Partner to Advance Cultivated Leather TechnologyMeatable and Pelagen have entered a collaboration aimed at enhancing the production of animal-free leather using Meatable's opti-ox™ technology. The partnership focuses on refining media composition and processing techniques to optimize efficiency, cost-effectiveness, and product quality in cultivating leather. This initiative marks Meatable's diversification into sustainable materials beyond the food industry.UniiqUNIIQ-investering voor Leidse biotech startup Pelagen voor duurzamere manier om natuurlijke materialen zoals leer te producerenUNIIQ has invested in Pelagen, a biotech startup based at the Leiden Bio Science Park, to further develop technology for producing natural materials like leather without using animals. This investment aims to scale a process that replicates animal-based material components in a lab, offering a sustainable alternative to traditional livestock farming and plastic-based vegan alternatives.